| Literature DB >> 28807572 |
Aya Futamura1, Dai Nozawa2, Yuko Araki2, Yunoshin Tamura2, Seiken Tokura2, Hiroshi Kawamoto2, Yuichi Tokumaru3, Sora Kakihara3, Takeshi Aoki3, Norikazu Ohtake2.
Abstract
The design, synthesis, and structure activity relationships of the novel class of pyrazolylethylbenzamide orexin receptor 1-selective antagonists are described. Further derivatization of the prototype dual orexin receptor 1/2 antagonist lead (1) by installing a (S)-methyl group into the ethyl linker moiety between the pyrazole ring and benzamide resulted in an increase of the antagonist potency against orexin receptor 1/2 receptors. Optimization of the benzamide and pyrazole parts of compounds 2 and 9b led to the identification of N-ethyl-5-fluoro-N-{(2S)-1-[5-(4-fluorophenyl)-2H-tetrazol-2-yl]propan-2-yl}-2-(pyrimidin-2-yl)benzamide (24), which exhibited excellent antagonistic activity against orexin receptor 1 with an IC50 of 2.01nM and a 265-fold selectivity for orexin receptor 1 over orexin receptor 2.Entities:
Keywords: Dual orexin receptor antagonist (DORA); Orexin 1; Selective orexin receptor antagonist (SORA)
Mesh:
Substances:
Year: 2017 PMID: 28807572 DOI: 10.1016/j.bmc.2017.07.051
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641